Targeting difficult to treat cancer
Extra programs on pipeline
Targeting CNS diseases
Three patented novel technology platforms: Partnership CAAD for regular therapeutic antibody design: Service
Ab Studio Inc. is a biotech startup that was founded in the San Francisco Bay Area in February 2017. Our founder and leading scientist have extensive expertise in the field of therapeutic antibody discovery, lead selection, engineering, humanization, and optimization.
We look forward to developing novel therapeutic antibodies to target difficult-to-treat diseases via a combination of computer-aided design and traditional antibody discovery technologies.